Immune response of patients with recurrent Aphthous Stomatitis challenged with a symbiotic

Abstract

Background

There are indications that Th1 polarization of immune response plays an important role in the pathogenesis of Recurrent Aphthous Stomatitis (RAS), and that the use of probiotics can stimulate immune regulatory activity, influencing the course of the disease. The aim of the present study was to characterize the initial immune profile of RAS patients and evaluate clinical and serological response following a challenge with symbiotic treatment containing fructooligosaccharide, Lactobacillus and Bifidobacterium.

Methods

the immune responses of the 45 patients with RAS, submitted to symbiotic or placebo for 120 days, in relation to 30 RAS-free controls, were evaluated over a period of six months. Peripheral blood was collected from all patients at 0 (T0), 120 (T4), and 180 days (T6) after the start of treatment and Th1 (IL12-p70, IFN-γ), Th2 (IL-4), Treg (IL-10), Th17 (IL-17A), inflammatory (TNF-α, IL-6) associated cytokines and clinical parameters were quantified.

Results

At T0, significant differences were found in the serological levels of the IFN-γ, IL-4, and IL-6 cytokines of the RAS patients in comparison with the controls. It was observed that the cytokine profile of the RAS group was comprised of two distinct clusters: a pure Th2 and a Mixed (Th1/Th2) subtype; and that symbiotic treatment induced an improvement in pain and an increase of IFN-γ levels, producing a reduction in Th2 response.

Conclusions

In RAS, symbiotic treatment based on a fructooligosaccharide, Lactobacillus and Bifidobacterium composition produced an alteration in the Th2 serological immune profile in the direction of Th1 and improved pain symptomatology.

This article is protected by copyright. All rights reserved.

http://ift.tt/2wd5GvZ